Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Zynerba Pharma CS (NASDAQ: ZYNE)

$19.00 USD $0.09 (0.48%)
Last Price $19
Net Change $0.09 (0.48%)
Bid $0
Ask Price $0
Open Price $18.94
Previous Close Price $18.91
High Price $19.1
Low Price $18.58
Number of Trades 952
Volume 188,900
Fifty Two Week High $25.95 (2017-04-13)
Fifty Two Week Low $6.31 (2016-06-29)
Average Daily Volume 452,492
Share Outstanding 13,250 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.6 (2017-05-09)
2nd Quarter Earnings $-0.71 (2017-03-27)
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $7.56
Recent Earnings $-0.6
Annual EPS $-2.68
Last Quarter EPS $
Market Capitalization $0.25B
Insider Shareholders % 0.1002%
Annual Revenue $0B
No. Shares Outstanding 13,250
Inst. Shareholder % 30%
Annual Net Income $-0.03B
TTM Net Profit Margin $0
1-Year Return 145.16%
3-Year Return 16.92%
5-Year Return 16.92%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 7.56%
Dividends per Share $
Stock Split Ratio
Beta 5.19
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates which are in clinical trial stage include ZYN002 and ZYN001 synthetic transdermal cannabinoid therapeutics for indications including refractory epilepsy, Fragile X syndrome, osteoarthritis, fibromyalgia and peripheral neuropathic pain. Zynerba Pharmaceuticals, Inc. is headquartered in Devon, Pennsylvania.